WO2012033348A3 - 2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물 - Google Patents

2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2012033348A3
WO2012033348A3 PCT/KR2011/006633 KR2011006633W WO2012033348A3 WO 2012033348 A3 WO2012033348 A3 WO 2012033348A3 KR 2011006633 W KR2011006633 W KR 2011006633W WO 2012033348 A3 WO2012033348 A3 WO 2012033348A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
treatment
allergic diseases
composition
linoleoyl glycerol
Prior art date
Application number
PCT/KR2011/006633
Other languages
English (en)
French (fr)
Other versions
WO2012033348A2 (ko
Inventor
오좌섭
안은경
이재연
홍성수
송명종
고혜진
Original Assignee
(재)경기과학기술진흥원 천연물신약연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (재)경기과학기술진흥원 천연물신약연구소 filed Critical (재)경기과학기술진흥원 천연물신약연구소
Publication of WO2012033348A2 publication Critical patent/WO2012033348A2/ko
Publication of WO2012033348A3 publication Critical patent/WO2012033348A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/342—Adenophora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 2-리놀레오일 글리세롤(2-linoleoyl glycerol) 또는 이의 약학적으로 허용 가능한 염을 포함하는 알러지성 질환의 예방 또는 치료용 약제학적 조성물에 관한 것으로, 보다 자세하게는 잔대(사삼) 추출물 및/또는 이로부터 분리된 2-리놀레오일 글리세롤(2-linoleoyl glycerol)을 유효성분으로 포함하는 알러지성 질환의 예방 또는 치료용 약제학적 조성물, 상기 질환들의 개선용 식품 조성물에 관한 것이다.
PCT/KR2011/006633 2010-09-08 2011-09-07 2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물 WO2012033348A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0087766 2010-09-08
KR1020100087766A KR101318896B1 (ko) 2010-09-08 2010-09-08 2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물

Publications (2)

Publication Number Publication Date
WO2012033348A2 WO2012033348A2 (ko) 2012-03-15
WO2012033348A3 true WO2012033348A3 (ko) 2012-05-31

Family

ID=45811081

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/006633 WO2012033348A2 (ko) 2010-09-08 2011-09-07 2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물

Country Status (2)

Country Link
KR (1) KR101318896B1 (ko)
WO (1) WO2012033348A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101686431B1 (ko) * 2015-06-11 2016-12-15 대한민국 잔대 잎 추출물을 포함하는 염증성 질환 예방 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796459B1 (ko) * 2006-10-10 2008-01-21 재단법인서울대학교산학협력재단 항염, 항알레르기 및 항천식 활성을 갖는 지방산 글리세롤유도체 및 이를 유효성분으로 함유하는 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796459B1 (ko) * 2006-10-10 2008-01-21 재단법인서울대학교산학협력재단 항염, 항알레르기 및 항천식 활성을 갖는 지방산 글리세롤유도체 및 이를 유효성분으로 함유하는 조성물

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHIN, D.H. ET AL.: "The Experimental Studies on the Immunomodulational Effects of Adenophorae Radix.", KOREAN JOURNAL OF HERBOLOGY., vol. 15, no. 1, 2000, pages 31 - 43 *
SUGIURA, T. ET AL.: "Evidence That 2-Arachidonoylglycerol but Not N- Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor.", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 1, 2000, pages 605 - 612 *

Also Published As

Publication number Publication date
WO2012033348A2 (ko) 2012-03-15
KR101318896B1 (ko) 2013-10-23
KR20120025707A (ko) 2012-03-16

Similar Documents

Publication Publication Date Title
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
WO2015018380A3 (en) Therapeutic nanoparticles and the preparation methods thereof
WO2011076749A3 (en) Solid pharmaceutical dosage form of ticagrelor
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
EP3626253A3 (en) Stable formulations of linaclotide
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
WO2013183062A3 (en) Palatable formulations of ibuprofen
WO2010116385A3 (en) Pharmaceutical compositions for alleviating unpleasant taste
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
WO2012053013A3 (en) Pharmaceutical compositions of anti-acne agents
WO2010090494A3 (ko) 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
WO2013019091A3 (en) A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011101734A3 (en) Taste-masked powder for suspension compositions of methylprednisolone
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
WO2012064302A3 (en) Improved montelukast formulations
WO2009041786A3 (en) Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper longum for the prevention and treatment of inflammatory disease
WO2011052935A3 (ko) 토복령, 여주 및 동충하초 추출물을 유효성분으로 포함하는 혈당 강하용 조성물
WO2011060253A3 (en) Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
WO2008116737A3 (de) Kapseln enthaltend pflanzenzubereitungen
MX2010004513A (es) Proceso de obtencion de un extracto estandarizado, extracto obtenido, composicion farmaceutica, metodo de tratamiento y uso de dicho extracto.
ES2325291A1 (es) "uso de un extracto de silybum marianum"

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11823781

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11823781

Country of ref document: EP

Kind code of ref document: A2